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Abstract
Background: Young adults with type 2 diabetes (aged 18–39 years) are at risk of early onset and rapid progression
of diabetic retinopathy, the leading cause of blindness and vision loss in working age adults. Early detection via
retinal screening can prevent most vision loss, yet screening rates are consistently lower among this priority
population than the general diabetes population. We aimed to test the effect of a tailored, evidence-based brief
health behaviour change intervention (leaflet) on self-reported screening uptake, and previously identified social
cognitive determinants of retinal screening.
Methods: A pragmatic, two-arm randomised controlled trial was conducted from September 2014 to April 2015.
Participants were stratified by prior screening uptake (Yes/No) and randomly allocated to intervention (leaflet) or
‘usual care’ control (no leaflet). Primary outcome was self-reported screening uptake four weeks post-intervention
for ‘No’ participants who had not previously screened for diabetic retinopathy. Secondary outcome variables were
changes in knowledge, attitudes, normative beliefs, intention and behavioural skills for all participants, irrespective
of prior screening behaviour. To assess intervention effects on secondary outcome variables, we conducted
independent samples t-tests (two-tailed) on pre-post change scores.
Results: 129 young adults (26% no prior retinal screen) completed baseline; 101 completed post-intervention.
Power to determine effect on the primary outcome was curtailed by low recruitment of individuals with no prior
retinal screen and loss to follow-up. Attrition was associated significantly with country of birth, language spoken at
home, and marital status. Significant intervention effect was observed for one secondary outcome variable:
knowledge of diabetic retinopathy (p = .03) with moderate effect (partial eta squared η2 = .05); no adverse effects
were reported. Control group participants received the leaflet at study completion.
Conclusions: This study confirms that a well-designed eye health and retinal screening promotion leaflet can increase
knowledge of diabetic retinopathy, an important screening predictor. The study highlights the challenges of conducting
‘real-world’ health behaviour change research with this priority population, providing insights for clinicians and researchers.
Strategies to recruit, engage and retain hard-to-reach populations are discussed including nonconventional alternatives to
randomised controlled trial designs. Trial registration: ACTRN12614001110673, UTN No.: U1111–1161-9803. Registered 20
October 2014 - retrospectively registered https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=367127.
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Background
The increasing incidence of type 2 diabetes (T2D) in
young adults (aged 18–39 years) and associated morbidity
and mortality has generated significant concern in recent
years [1]. Clinical and population-based studies highlight
the aggressive nature of younger-onset T2D, and conse-
quent risk of diabetes-related complications by mid-life
[2]. Younger age of T2D onset is an independent risk fac-
tor for diabetic retinopathy (DR); the leading cause of
vision loss and blindness in working-age adults worldwide
[3]. Retinal screening (hereafter ‘screening’) is the proven
clinical pathway to early detection of DR and prevention
of vision loss [4]. Guidelines recommend screening for DR
at T2D diagnosis, repeated periodically thereafter [5–7].
Despite this, there is less take up or initiation of screening
(hereafter ‘uptake’) among young adults with T2D when
compared with other groups [8, 9]. In Australia, screening
rates in this priority population are estimated to be 55%,
compared with 78% in the general diabetes population
[10, 11]. A range of barriers to retinal screening have been
identified among this group [12–14], leading to calls for
tailored, age-appropriate intervention [15, 16].
Effective interventions to promote health behaviour
change have shared elements: content grounded in evi-
dence, underpinned by theoretical constructs; targeting
identified behavioural determinants [17]. Using a co-design
approach, our multidisciplinary project team developed an
evidence-based and theoretically-grounded screening pro-
motion leaflet, targeting factors previously identified as
impacting screening behaviour among young adults with
T2D [12, 18, 19]. The leaflet was developed to appropriate
literacy standards with the input of the priority population
and sector stakeholders and has been acknowledged as an
example of best practice [20].
The aim of the current study was to test, in a two-arm,
parallel-groups randomised controlled trial (RCT), effect of
the Who is looking after your eyes? leaflet (Figs. 1 a & b). We
had two hypotheses: 1) participants who had not engaged
with DR screening since T2D diagnosis (hereafter ‘unen-
gaged’) and who received the leaflet, would be more likely to
initiate screening than unengaged participants who did not
receive the leaflet (primary outcome: uptake of screening);
2) all participants who received the leaflet (irrespective of
whether they had previously engaged in screening) would
show improvement in previously-identified social cognitive
determinants of screening behaviour (secondary outcome:
change in social cognitive factors).
Methods
Study design and randomisation
Trial design and registration
A pragmatic, two-arm RCT design was conducted from
October 2014 to April 2015. The study was retrospect-
ively registered with Australian New Zealand Clinical
Trials Registry, six weeks after recruitment commenced
and before randomisation (ACTRN12614001110673,
UTN No.: U1111–1161-9803).
Sample size calculation and change to trial design after
trial commencement
Informed by previous studies [9, 10, 21–23], we antici-
pated 10% recruitment, 50% baseline screening rate
and 40% study attrition. We initially selected a Solo-
mon 4-group design [24] to account for anticipated
Question-Behaviour-Effect (QBE), where answering
questions about a specific behaviour can influence an
individual’s related cognitions, emotions and behaviour
[25]. Thus, our initial sample size calculation required
200 unengaged participants (50 per condition in the 4-
group design). Calculation used input parameters: ef-
fect size of 0.3 [26], 80% power, significance level of
0.05, two-tailed.
However, lower than expected recruitment of unen-
gaged participants in the first few weeks foreshadowed risk
of lack of power to detect change in the primary outcome.
Consequently, changes were made to trial design (see
Additional file 2 for more detail) where: prior to random-
isation, the design was modified to a conventional two-
arm (intervention/control) RCT, and alternate methods
were used to minimise the potential impact of QBE (see
Concealment of Study Purpose below). Using the revised
design and existing input parameters, 25 unengaged par-
ticipants in each arm were required to sufficiently power
the study to determine effect on the primary outcome.
Participants
Eligibility
Young adults with T2D (18–39 years) registered with
Australia’s National Diabetes Services Scheme (NDSS)1
were eligible to participate, with registration date used
as a proxy for diabetes diagnosis. With approximately
90% of Australians with T2D registered, the NDSS is
considered the “best available source to monitor type 2
diabetes in children and young people in Australia” [27].
Exclusion criteria were non-proficiency in English and
other diabetes types.
Recruitment
Of the approximately 32,000 young adults with T2D
registered on the NDSS, 5354 had consented to be
contacted for research purposes; all were invited to
participate. To protect confidentiality, NDSS staff
1The NDSS is an initiative of the Australian Government administered
with the assistance of Diabetes Australia. It supports people with
diabetes to self-manage their condition by providing subsidised access
to diabetes-related products and services.
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coordinated study recruitment, including an introduc-
tory letter (on NDSS/Diabetes Australia letterhead)
and study invitation. Two incentives were offered: a
chance to win one of three iPad minis at registration/
Stage 1 data collection, AUD$20 upon study comple-
tion. A reminder invitation was posted four weeks
later and recruitment continued until online study en-
rolment waned.
Fig. 1 ‘Who is looking after your eyes?’ leaflet. ©Vision 2020 Australia 2020, all rights reserved. Panels numbered in typical reading order. Available
at: https://bit.ly/2mvJ6yE
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Concealment of study purpose
The purpose of the study was initially concealed to miti-
gate risk of young adults with T2D who had not engaged
in screening declining to participate in a study focused
on the behaviour. Consequently, the study invitation ad-
vertised the opportunity to participate in a study about
‘diabetes self-management’ with the question about
screening status embedded within a suite of items ex-
ploring diabetes self-management activities.
Procedure
Data collection was managed via Qualtrics secure on-
line survey platform (Qualtrics, Provo, UT). Baseline
data was collected in two stages to allow identifica-
tion of participants who had already engaged in
screening. Participants were stratified based on en-
gagement with screening and then randomly allocated
to ‘leaflet’ intervention or ‘no leaflet’ control. Ran-
domisation sequence was generated by the project
manager (AJL) via an online random number gener-
ator using a 1:1 ratio [28].
Following a two-month development and piloting process
(January to February 2015), the leaflet was posted to all
intervention participants in March 2015. Four weeks later,
all participants were emailed an invitation to complete a
follow-up survey, with survey logic programmed to ensure
that previously unengaged participants were asked whether
they had engaged in DR screening “since completing the
last survey”. The survey also contained all Stage 2 social
cognitive items and a fidelity question which asked inter-
vention group participants whether they received the leaflet,
and if so, whether they had read it.
Upon completion of the post-intervention survey, all
study participants were provided with a transparency
statement which explained: the reason for concealment
of the true study purpose, why screening is important
for all people with diabetes and a link to more informa-
tion. Control group participants who had been exposed
to real-world ‘usual care’ were invited to receive the
Who is looking after your eyes? leaflet upon provision of
their postal address.
Intervention
Development of the 8-panel, Who is looking after your
eyes? leaflet (Figs. 1 a and b) is described elsewhere [18].
Measures
Our survey was reviewed and pilot-tested by stake-
holders including young adults with T2D. Baseline data
were collected in two stages: i) demographics and clin-
ical characteristics, and ii) social cognitive determinants.
At 4-weeks post-intervention, items assessing engagement
with diabetes-related health checks (including screening),
emotional well-being and all social cognitive determinant
items were repeated.
Stage 1 Demographic data
Participants provided written consent and demographic
data, including gender, age, country of birth, language
spoken at home, marital status, level of education, em-
ployment status, primary diabetes management, family
history of T2D and number of health comorbidities.
Engagement with diabetes-related health checks: was
assessed via six separate questions, worded as follows:
‘Since you were diagnosed with diabetes, have you had
your [cholesterol, blood pressure, average blood glucose
(HbA1c), kidney function, eye health, feet] checked?’. A
standard definition was provided for each with the aim of
minimising reported confusion between standard vision
check and screening for DR [29]. Responses to the eye
health check component of this question were used to
identify: unengaged participants to determine uptake of
screening 4-weeks post-intervention (primary outcome).
Depressive symptoms: the Patient Health Questionnaire-
2 (PHQ-2) [30], a brief, validated depression screening tool,
was included, to identify potential harms arising from the
intervention. Responses to PHQ-2 items were summed to
produce a total score (range: 0–6), with higher scores indi-
cating more depressive symptoms.
Stage 2 Social cognitive determinants
We have previously reported the theory-based develop-
ment of the 54-item survey used in this study [18]; all
items are listed in Additional file 1. In brief, 16 items
assessed three knowledge constructs (link between dia-
betes and vision loss, knowledge of DR, and knowledge
of screening). Responses were scored dichotomously
(correct / incorrect). Knowledge items were aggregated
to form a composite score with higher scores indicating
greater knowledge.
Twenty-one items assessed three attitude constructs:
i) attitudes to screening, ii) perception of personal
risk and iii) anticipated regret at not screening. Three
items assessed normative beliefs (such as approval of
others and beliefs about the behaviour of similar
others) and a further three items assessed intention
to screen for DR. For attitudes, normative belief and
intention items, responses were scored on either a 5-
or 7-point Likert scale, with higher scores represent-
ing stronger agreement (items reverse scored where
necessary).
Finally, eleven items assessed two behavioural skills
constructs: i) perceived control (e.g. ability to seek and
attend screening) and ii) overcoming barriers (e.g. ability
to identify and address common environmental and psy-
chosocial barriers). Responses were scored on a 5-point
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Likert scale with higher scores representing greater
confidence.
Statistical analyses
Data were analysed using the Statistical Package for
Social Sciences (SPSS, IBM Corp, Armonk, NY; Ver.23,
2015). To assess factors associated with loss to follow-
up, chi-square and independent t-tests (two-tailed) were
used to compare baseline demographic characteristics
and scores on modifiable behavioural determinants be-
tween those who completed and did not complete the
study.
Primary outcome: we planned to perform inferential
statistical analyses to determine the effect of the interven-
tion on uptake of DR screening. However, insufficient ‘un-
engaged’ participants provided post-intervention data. As
such, the study was underpowered to determine effect of
the leaflet on the primary outcome.
Secondary outcome: to assess intervention effects on
secondary outcomes, we: i) created change scores by
subtracting the baseline composite scores from those at
follow-up, ii) conducted independent samples t-tests
(two-tailed) on the change scores to assess between-
group differences and also conducted paired-samples t-
tests to assess within-group changes over time, and iii)
calculated effect sizes to determine the relevance of the
finding.
Although intention-to-treat and per-protocol analyses
were planned, high attrition precluded reliable analysis.
Consequently, we elected to exclude cases with missing
secondary outcome data pairwise, restricting results to
complete cases only for each individual behavioural deter-
minant composite score. Data are presented as means±
standard deviation (SD), median (interquartile range, IQR)
or n(%). Statistical significance was defined as p < 0.05. Ef-
fect sizes are described with partial eta squared (η2, range:
0–1); guidelines for interpretation are: η2 = 0.01 (small),
η2 = 0.06 (moderate), and η2 = 0.14 (large effect) [31].
Results
Participant flow
Of the 5354 young adults with T2D invited to participate,
273 (5%) visited the study website and completed eligibil-
ity screening (see participant flow, Fig. 2). Of those, 227
(83.2%) were eligible, consented to participate and com-
pleted the Stage 1 baseline survey (demographic data). At
the end of the seven-week recruitment period, 129 (56.8%
of the eligible 227 study registrants) completed the Stage 2
baseline survey (social cognitive data). Of those, 101
(78.3%) completed the follow-up survey, 4-weeks later.
While there was considerable attrition over the course of
the study, there was no evidence of differential attrition
between treatment arms (all p > .05, data not shown).
Those who completed the study (‘completers’) differed
significantly from ‘non-completers’ on three characteristics:
compared to non-completers, study completers were sig-
nificantly more likely to be i) Australian-born (71% vs 48%,
p = .001), ii) speak English at home (87% vs 71%, p = .005),
and iii) less likely to be married (61% vs 76%, p = .024).
Baseline characteristics
The average age of the total sample (Stage 1: N = 227)
was 34 ± 4 years (range: 19–39 years); 56% (n = 126) were
women, 78% (n = 177) spoke English at home, 58% (n =
131) were born in Australia and 29% (n = 64) were born
in Asia. Overall, participants reported short average dur-
ation of T2D (1.6 ± 2.5 years), with 66% (n = 150) man-
aging their diabetes with oral hypoglycemic agents and
87% (n = 197) reporting having engaged with four or
more diabetes-related health and complication checks
since their diagnosis. Importantly, 72% (n = 164) had
already engaged with DR screening.
For those who also provided Stage 2 baseline data (n =
129), knowledge of an association between diabetes and
vision loss was high (1.96 ± 0.20); but lower for know-
ledge of DR (6.46 ± 2.12) and screening (1.47 ± 0.63).
Participants reported high baseline intention to engage
in screening (18.45 ± 5.01), strong perceptions of others’
approval (normative beliefs, 13.26 ± 2.12), but only mod-
erate perception of personal risk (12.78 ± 4.38) and an-
ticipated regret at not screening (24.64 ± 6.39). Finally,
participants reported moderately positive attitudes to
screening at baseline (46.14 ± 6.44), perceived control in
attending screening (23.87 ± 5.17) and overcoming bar-
riers (19.57 ± 4.41).
Demographic and social cognitive characteristics of
participants who provided both Stage 1 and Stage 2
baseline data are presented by allocated study arm in
Table 1.
Primary and secondary outcomes
Baseline, post-intervention and change scores are pre-
sented for all outcome variables by allocated study arm
in Table 2.
Screening uptake among unengaged participants
Among the unengaged intervention group partici-
pants, there was a trend toward higher screening up-
take than among those in the control (no leaflet)
group (n = 5, 63% and n = 3, 25%, respectively). How-
ever, insufficient numbers of unengaged participants
provided post-intervention data (n = 24; 12 in each
arm) and the study was under-powered to detect
meaningful change on the primary outcome variable.
Lake et al. BMC Ophthalmology           (2020) 20:80 Page 5 of 12
Fig. 2 RCT participant flow diagram
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Table 1 Demographic and social cognitive characteristics of study participants who provided both Stage 1 and Stage 2 baseline
data, by allocated study arm
Intervention (n = 67) Control (n = 62)
Baseline demographic and clinical characteristics
Age, years 35.0 (31.0–37.0) 36.0 (33.8–37.3)
Gender: women 40 (60%) 37 (60%)
Country of birth: Australia 41 (61%) 43 (69%)
Main language spoken at home: English 57 (85%) 51 (82%)
Marital status: in a relationship 44 (66%) 39 (63%)
Education level:
Secondary 13 (20%) 15 (24%)
Trade or certificate 25 (37%) 24 (39%)
Tertiary 29 (43%) 23 (37%)
Employment status: in paid employment 37 (55%) 40 (65%)
Socioeconomic status (SEIFA)# 981.7 (73.8) 998.4 (68.3)
Diabetes duration, years 1.53 (2.11) 1.48 (1.78)
Primary diabetes management:
Lifestyle only 10 (15%) 16 (26%)
Oral medication 44 (66%) 43 (69%)
Insulin 13 (19%) 3 (5%)
Family history of T2D: yes 47 (70%) 47 (76%)
Total diabetes-related health checks (range 0–6) 4.67 (1.31) 4.60 (1.50)
Health comorbidities, number 1.79 (1.33) 1.75 (1.45)
Depressive symptoms (PHQ-2, range 0–6) 2.67 (2.15) 2.15 (1.98)
PRIMARY OUTCOME (engaged with retinal screening since diabetes diagnosis)
Yes (‘engaged’) 48 (72%) 44 (71%)
No (‘unengaged’) 19 (28%) 18 (29%)
SECONDARY OUTCOME VARIABLES (social cognitive determinants)
Knowledge
Knowledge of diabetes/vision link (range 0–2) 1.97 (0.18) 1.94 (0.23)
Knowledge of diabetic retinopathy (range 0–11) 6.28 (2.20) 6.66 (2.03)
Knowledge of retinal screening (range 0–3) 1.46 (0.56) 1.48 (0.70)
Attitudes
Retinal screening (range 11–55) 46.19 (5.62) 46.12 (7.31)
Risk perception (range 4–28) 13.23 (4.46) 12.26 (4.27)
Anticipated regret (range 6–42) 24.73 (6.19) 24.53 (6.65)
Normative beliefs (range 2–14) 13.41 (1.96) 13.09 (2.29)
Intention (range 3–21) 18.31 (4.78) 18.60 (5.29)
Behavioural skills
Perceived behavioural control (range 6–30) 23.58 (5.11) 24.20 (5.27)
Overcoming barriers (range 5–55) 19.41 (4.25) 19.75 (4.61)
Data are mean (SD), number (%); age reported as median (IQR)
#Socio-Economic Indexes For Areas scores are standardised against a mean of 1000; lower scores indicate disadvantage less than the national
average abs.gov.au/websitedbs/censushome.nsf/home/seifa
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Social cognitive determinants
Among all study participants (irrespective of previous
screening status), independent-samples t-tests demonstrated
no significant between-group differences (all p > .05), with
the exception of knowledge of DR which increased more
among participants in the leaflet intervention arm relative to
the control group (M= 1.21, SD = 2.58 and M= 0.08, SD=
2.07, respectively), (t(72) =− 2.213, p = .03). The magnitude
of the difference in the means was moderate (mean differ-
ence = 1.12, 95% CI: − 2.14 to 0.11; partial eta squared = .05).
Table 2 Primary and secondary outcomes by allocated study arm and time point
Time point Intervention Control
Primary outcome: Unengaged participants n = 8 n = 12
Retinal screening uptake since baseline Baseline 0 0
4 weeks 5 3
Secondary outcomes#:All participants n = 43 n = 51
Knowledge of: Diabetes/vision link (range 0–2) Baseline 1.97 (.17) 1.96 (.21)
4 weeks 1.97 (.17) 1.98 (.15)
Change 0.00 (0.24) 0.02 (0.15)
Diabetic retinopathy (DR) (range 0–11) Baseline 6.43 (2.38) 6.78 (2.00)
4 weeks 7.64 (1.97)b* 6.86 (2.10)
Change 1.21 (2.58)a* 0.08 (2.07)
Retinal screening (range 0–3) Baseline 1.45 (.55) 1.42 (.70)
4 weeks 1.70 (.72)b* 1.72 (.70)b*
Change 0.25 (0.78) 0.30 (0.68)
Attitudes: Retinal screening (range 11–55) Baseline 46.29 (4.99) 46.28 (6.17)
4 weeks 46.61 (5.70) 45.85 (5.4)
Change 0.32 (4.36) −0.43 (4.14)
Risk perception (range 4–28) Baseline 13.49 (4.24) 12.30 (4.08)
4 weeks 13.64 (3.91) 12.17 (3.57)
Change 0.15 (3.18) −0.13 (3.35)
Anticipated regret (range 6–42) Baseline 24.62 (5.96) 24.79 (5.55)
4 weeks 30.67 (5.85)b* 29.40 (7.16)b*
Change 6.05 (5.53) 4.62 (5.75)
Normative beliefs (range 2–14) Baseline 13.26 (2.28) 13.43 (1.44)
4 weeks 13.10 (2.34) 13.02 (2.66)
Change −0.15 (2.38) −0.40 (2.21)
Intention (range 3–21) Baseline 18.51 (4.61) 18.72 (5.22)
4 weeks 18.46 (4.01) 18.83 (4.36)
Change −0.05 (4.38) 0.11 (2.12)
Behavioural skills: Perceived control (range 6–30) Baseline 24.72 (4.10) 24.50 (4.38)
4 weeks 25.28 (4.24) 24.11 (4.97)
Change 0.56 (3.48) −0.39 (4.22)
Overcoming barriers (range 5–25) Baseline 20.21 (3.27) 19.91 (4.08)
4 weeks 20.08 (3.43) 19.15 (4.17)
Change −0.13 (3.26) −0.77 (3.44)
Depressive symptoms (PHQ-2, range 0–6) Baseline 2.38 (2.42) 1.94 (1.96)
4 weeks 2.05 (2.04) 2.00 (2.01)
Change −0.33 (1.78) 0.06 (1.68)
Primary outcome: number of unengaged participants who reported receiving and reading leaflet
Secondary outcomes (all participants): mean (standard deviation); change score = follow-up score minus baseline score (standard deviation); # Some missing data: range
3–10 dependent upon variable; a Significant between-condition difference in change scores; b Significant within-condition difference in change scores; *p < .05
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Participants in both treatment arms reported signifi-
cant increases in knowledge of screening and anticipated
regret (p < .05); however, there were no significant
between-group difference in change scores.
Fidelity
The Who is looking after your eyes? leaflet was received
and read by 43 of the 50 (86%) intervention group par-
ticipants. Seven participants either did not receive (n = 5)
or did not read (n = 2) the leaflet (with the latter citing
‘lack of time’) and were excluded from outcome analyses.
The final post-intervention analysis sample comprised
N = 94 participants (n = 43 intervention; n = 51 control).
Depressive symptoms
PHQ-2 scores were moderate and did not significantly
increase over time or differ between groups. No adverse
events were reported.
Discussion
Summary of findings
To our knowledge, this is the first randomised con-
trolled trial of a tailored intervention designed to engage
young adults with T2D with retinal screening. Despite
lack of power to assess whether the leaflet increased up-
take of screening for unengaged participants, trends in
the expected direction were positive. The leaflet was
received and read by 86% of the intervention group,
demonstrating program fidelity. Overall, however, no
firm conclusions can be drawn about the impact of the
leaflet on the primary outcome.
The effect of the leaflet on secondary outcomes was
promising, with demonstrated increase in knowledge of
DR, an important screening enabler [32]. The moderate
effect size observed is consistent with those found else-
where in behavioural medicine [26]. Although the leaflet
intervention did not independently impact other identi-
fied social cognitive determinants, study involvement
was associated with improved knowledge of screening
and high anticipated regret, highlighting implications for
health policy and practice.
Limitations
This study has several limitations. Despite rigorous design,
careful planning, broad consultation and a nationwide re-
cruitment program, only 4% of eligible NDSS registrants
participated. It is likely that low recruitment resulted from
a confluence of cohort-specific barriers (e.g. busy life
stage, high rates of depression; 21, 23, [33] and context-
specific barriers (e.g. study fatigue from concurrent
NDSS-supported research programs, personal communi-
cation, D. Rae, National Operations Manager NDSS).
The low overall sample size combined with a high
baseline screening rate (72%) resulted in a lack of power
to detect change in the primary outcome. Although
similar to the general diabetes population screening rate
in Australia (78%, 11) national and international data
suggest that the true younger adult screening rate is
closer to 50% [9, 10], indicating that the current study is
likely to have experienced recruitment bias. Possible ex-
planations for recruitment bias, which favors high self-
reported screening rates, include: self-selection bias and
social desirability and recall bias [34]. Despite efforts to
conceal the true nature of the study, asking about self-
management behaviour from the outset may have elic-
ited a social desirability bias, of which younger people
are considered susceptible [26]. Accuracy of self-report
is also vulnerable to recall bias, particularly in the light
of acknowledged confusion regarding the difference be-
tween screening for DR and a standard eye check [29].
Future studies could overcome risk of bias by not only
including definition of screening (as was done in the
current study) but also corroboration of self-report with
clinical record data [35].
Moderate-to-high baseline scores (ceiling effect) for
many of the social cognitive factors indicated favorable
beliefs and attitudes to screening. Consequently, there was
limited potential to detect an intervention effect on sec-
ondary outcome variables. Further, as we would expect to
see the greatest change in social cognitive determinants in
unengaged participants, the low representation of unen-
gaged young adults with T2D may have exacerbated this
issue.
Further, the finding that country of birth and language
spoken at home were independently related to attrition
is important because of the high representation of
people of South Asian origin among young adults with
T2D [36]. The impact of marital status on attrition is
less clearly understood. Making the generalisation that
those in marital relationships may be more likely to have
children, it is possible that the burden of child-rearing
may have influenced ongoing study participation.
Implications for policy and practice
Young adults with T2D are characterised by high levels
of diabetes-specific distress and depressive symptoms,
lower diabetes self-efficacy and impaired quality of life,
and report feeling shame and negative judgement for
having a condition usually associated with older adult-
hood [37]. The combined consequence of these factors
are lack of engagement with support networks and low
screening uptake [8, 38]. An age-appropriate resource
delivered directly to young adults with T2D may present
one of the few opportunities for intervention.
However, as retinal screening determinants are multi-
level and multi-factorial, it is likely that even a well-
designed leaflet will be insufficient to change behaviour on
its own, a conclusion reached by earlier studies into the
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effect of screening promotion leaflets targeting general
practitioners, and other health behaviour change leaflets
targeting youth [39, 40]. Instead, resources, such as this
are more likely to be of value if implemented as part of a
coordinated initiative which utilises registration, recall and
reminders to improve rates of screening [32].
Thus, we make three recommendations. First, consid-
ering that most interventions to promote screening
achieve statistically significant increases in screening
rates [32] and that QBE effects have been demonstrated
in other socially desirable behaviours [41], we recom-
mend utilisation of QBE as a strategy for policy and
practice. The simple act of asking questions about
screening may be sufficient to prompt uptake. Second,
‘number of cues’ has been identified as a predictor of up-
take of pre-pregnancy care for young adult women with
T2D [42]. Similarly, increasing the number of screening
cues for young adults with T2D may have the effect of
achieving a ‘tipping point’ to prompt action. Again, the
relevance, and quality of messaging is a crucial consider-
ation. Finally, the Who is looking after your eyes?’ leaflet
was, by necessity, print-based in a size that could be
posted to participants [18]. In future, we recommend
that the messaging and content be used in the digital
platforms accessed by this priority population.
Implications for future research
Considering that participant recruitment was conducted
with the support and involvement of leading national eye
health and diabetes stakeholders, and that invitations were
extended nationwide to over 5000 eligible young adults
with T2D utilising the “best available” platform, replica-
tion is not a practical option and alternate evaluation
designs need to be considered. One solution advanced in
biomedical clinical trials involves a consortium approach
to simultaneously evaluate medical treatments while shar-
ing the one placebo arm [23, 33]. However, this is not
practical for smaller-scale programs.
Instead, emerging literature on non-conventional evalu-
ation designs for small samples offer alternatives which
aim to maintain rigor while maximising statistical power
for populations of limited sample size [43]. Dependent
upon a variety of factors (e.g. time, priority population
characteristics, intervention setting and dose), approaches
range from mixed-methods, stepped wedge and inter-
rupted time-series, to dynamic waitlisted and regression
point displacement designs. However, if a conventional,
gold standard RCT design is desired (and a sufficient sam-
ple size is achievable), a Solomon 4-group design [24] may
be needed to account for the likely presence of QBE.
Finally, our experience suggests that future research
programs would need to make concerted efforts from
the outset to recruit young adults with T2D from cultur-
ally and linguistically diverse communities. Suggestions
include: collaboration with community-based organisa-
tions and faith centers, language sensitivity and compe-
tency, and personal contact [32, 44].
Conclusion
The aim of this study was to evaluate a tailored, evidence-
based leaflet to promote screening uptake among young
adults with T2D. To date, there has been a lack of evidence-
based development of screening promotion resources
broadly, and a complete absence for young adults with T2D,
an under-researched, burgeoning priority population. Des-
pite rigorous study design and conduct, and proactive
recruitment and retention initiatives, we faced many of the
challenges experienced by ‘real-world’ health behaviour
change intervention studies conducted with diverse or disad-
vantaged groups. These included: low recruitment from a
small population base, high attrition, and consequent lack of
statistical power. Notwithstanding its limitations, this study
has demonstrated that a tailored, evidence-based leaflet can
improve knowledge of DR among young adults with T2D.
Other non-significant trends suggest the leaflet has the
potential to be useful for promoting uptake within a
broader, nationally-coordinated screening program and via
various media.
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